IMA ImageneBio, Inc.
Nasdaq · SEC CIK 1835579 · EDGAR
- Bought, last 12 months
- $95.8K 1 purchases by 1 insiders
- Sold, last 12 months
- $17.3K 1 sales by 1 insiders
- Filings on record
- 81 since 2021-11-23, latest 2026-08-17 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| SLATTERY JOSEPH P | Dir | $95.8K | — |
| Lally Robert B | Principal Accounting Off | — | $17.3K |
| Grant-Huerta Yanina | CFO | — | — |
| Butler Erin | Principal Accounting Off | — | — |
| Yarema Kristin | CEO, Dir | — | — |
Transactions 34
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-17 17:00 | 2026-08-14 | IMA | Yarema Kristin | CEO, Dir | A - Grant | $0.00 | +254.8K | 493.7K | +107% | $0 |
| DM | 2026-08-17 17:00 | 2026-08-14 | IMA | Grant-Huerta Yanina | CFO | A - Grant | $0.00 | +104.0K | 104.0K | New | $0 |
| D | 2026-07-28 16:05 | 2026-07-25 | IMA | Yarema Kristin | CEO, Dir | M - OptEx | $0.00 | +38.4K | 123.8K | +45% | $0 |
| D | 2026-07-28 16:05 | 2026-07-25 | IMA | Yarema Kristin | CEO, Dir | J - Other | $0.00 | +115.1K | 238.9K | +93% | $0 |
| M | 2026-07-20 21:47 | 2026-07-16+ | IMA | Lally Robert B | Principal Accounting Off | S - Sale | $5.42 | -3,196 | 55.6K | -5% | -$17.3K |
| D | 2026-03-18 | 2026-03-16 | IMA | Yarema Kristin | CEO, Dir | A - Grant | $0.00 | +85.4K | 85.4K | New | $0 |
| D | 2026-01-02 | 2025-12-30 | IMA | Butler Erin | Principal Accounting Off | A - Grant | $0.00 | +22.5K | 25.6K | +737% | $0 |
| 2025-12-29 | 2025-12-24 | IMA | SLATTERY JOSEPH P | Dir | P - Purchase | $5.99 | +16.0K | 16.0K | New | +$95.8K | |
| MI | 2025-10-10 | 2025-07-25 | IMA | Wang Stephen Hui | Dir | A - Grant | — | +250.7K | 50.1K | New | — |
| 2025-08-15 | 2025-07-25 | IMA | Wang Jonathan Jian | Dir | A - Grant | — | +143.8K | 143.8K | New | — | |
| I | 2025-08-15 | 2025-07-25 | IMA | Wang Jonathan Jian | Dir | A - Grant | — | +971.2K | 971.2K | New | — |
| I | 2025-07-30 | 2025-07-25 | IMA | ORBIMED ADVISORS LLC | Dir | A - Grant | $2.49 | +83.6K | 287.9K | +41% | +$208.2K |
| DI | 2025-07-30 | 2025-07-25 | IMA | Stampacchia Otello | Dir | P - Purchase | $29.90 | +267.6K | 455.0K | +143% | +$8.00M |
| D | 2025-07-30 | 2025-07-25 | IMA | Stampacchia Otello | Dir | M - OptEx | — | +379 | 379 | New | — |
| D | 2025-07-30 | 2025-07-25 | IMA | Bonita David P | Dir | M - OptEx | — | +379 | 379 | New | — |
| DI | 2025-07-30 | 2025-07-25 | IMA | Bonita David P | Dir | P - Purchase | $29.90 | +83.6K | 287.9K | +41% | +$2.50M |
| D | 2025-07-29 | 2025-07-25 | IMA | Butler Erin | Principal Accounting Off | A - Grant | — | +3,051 | 3,051 | New | — |
| D | 2025-07-29 | 2025-07-28 | IMA | Marango Jotin | CFO | F - Tax | $17.16 | -4,630 | 11.1K | -29% | -$79.5K |
| D | 2025-07-29 | 2025-07-28 | IMA | Marango Jotin | CFO | A - Grant | — | +15.8K | 15.8K | New | — |
| DAI | 2023-09-21 | 2023-08-04 | IMA | ORBIMED ADVISORS LLC | Dir | A - Grant | — | +153.1K | 5.58M | +3% | — |
| DAI | 2023-09-21 | 2023-08-04 | IMA | Bonita David P | Dir | A - Grant | — | +153.1K | 5.58M | +3% | — |
| DI | 2023-09-14 | 2023-08-04 | IMA | OrbiMed Capital GP VI LLC | Dir | A - Grant | — | +153.1K | 2.25M | +7% | — |
| DI | 2023-09-14 | 2023-08-04 | IMA | Bonita David P | Dir | A - Grant | — | +153.1K | 2.25M | +7% | — |
| MI | 2022-06-24 | 2022-06-22+ | IMA | OrbiMed Capital GP VI LLC | Dir | P - Purchase | $4.47 | -252.2K | 1.94M | -12% | -$1.13M |
| MI | 2022-06-24 | 2022-06-22+ | IMA | Bonita David P | Dir | P - Purchase | $4.47 | -252.2K | 2.10M | -11% | -$1.13M |
| DM | 2022-01-20 | 2022-01-18 | IMA | Tessier Maude | Chief Business Off | M - OptEx | $3.54 | +71.8K | 67.7K | New | +$253.8K |
| DM | 2022-01-12 | 2022-01-10+ | IMA | Zhang Xiaoyan Michelle | CSO | S - Sale+OE | $12.00 | -1,000 | 44.5K | -2% | -$12.0K |
| DM | 2022-01-12 | 2022-01-10+ | IMA | Zhang Xiaoyan Michelle | CSO | M - OptEx | $2.15 | +1,000 | 45.4K | +2% | +$2,150 |
| D | 2021-12-14 | 2021-12-10 | IMA | Zhang Xiaoyan Michelle | CSO | S - Sale+OE | $14.76 | -1,000 | 44.5K | -2% | -$14.8K |
| D | 2021-12-14 | 2021-12-10 | IMA | Zhang Xiaoyan Michelle | CSO | M - OptEx | $2.15 | +1,000 | 45.5K | +2% | +$2,150 |
| I | 2021-12-14 | 2021-03-30 | IMA | FORMELA JEAN FRANCOIS | Dir | P - Purchase | $16.00 | +125.0K | 874.6K | +17% | +$2.00M |
| MI | 2021-12-14 | 2021-12-10+ | IMA | FORMELA JEAN FRANCOIS | Dir | S - Sale | $14.67 | -26.3K | 1.26M | -2% | -$385.6K |
| I | 2021-12-14 | 2021-03-30 | IMA | Atlas Venture Associates Opportunity I, LLC | 10% | P - Purchase | $16.00 | +125.0K | 874.6K | +17% | +$2.00M |
| M | 2021-12-14 | 2021-12-10+ | IMA | Atlas Venture Associates Opportunity I, LLC | 10% | S - Sale | $14.67 | -26.3K | 1.26M | -2% | -$385.6K |